These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 9989969)

  • 1. Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes.
    Matoba S; Tatsumi T; Keira N; Kawahara A; Akashi K; Kobara M; Asayama J; Nakagawa M
    Circulation; 1999 Feb; 99(6):817-22. PubMed ID: 9989969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of beta-adrenergic receptor upregulation induced by ACE inhibition in cultured neonatal rat cardiac myocytes: roles of bradykinin and protein kinase C.
    Yonemochi H; Yasunaga S; Teshima Y; Iwao T; Akiyoshi K; Nakagawa M; Saikawa T; Ito M
    Circulation; 1998 Jun; 97(22):2268-73. PubMed ID: 9631877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats.
    Liu YH; Yang XP; Sharov VG; Sigmon DH; Sabbath HN; Carretero OA
    Hypertension; 1996 Jan; 27(1):7-13. PubMed ID: 8591891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
    Hartman JC
    Ann Thorac Surg; 1995 Sep; 60(3):789-92. PubMed ID: 7545893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of inhibition of angiotensin-converting enzyme on ischemic myocardium during coronary hypoperfusion in dogs.
    Kitakaze M; Minamino T; Node K; Komamura K; Shinozaki Y; Mori H; Kosaka H; Inoue M; Hori M; Kamada T
    Circulation; 1995 Aug; 92(4):950-61. PubMed ID: 7641379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotection with angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor antagonist is not abolished by nitric oxide synthase inhibitor in ischemia-reperfused rabbit hearts.
    Kawabata H; Ryomoto T; Ishikawa K
    Hypertens Res; 2001 Jul; 24(4):403-9. PubMed ID: 11510753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An AT1-receptor antagonist and an angiotensin-converting enzyme inhibitor protect against hypoxia-induced apoptosis in human aortic endothelial cells through upregulation of endothelial cell nitric oxide synthase activity.
    Matsumoto N; Manabe H; Ochiai J; Fujita N; Takagi T; Uemura M; Naito Y; Yoshida N; Oka S; Yoshikawa T
    Shock; 2003 Jun; 19(6):547-52. PubMed ID: 12785010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide-induced cardioprotection in cultured rat ventricular myocytes.
    Rakhit RD; Edwards RJ; Mockridge JW; Baydoun AR; Wyatt AW; Mann GE; Marber MS
    Am J Physiol Heart Circ Physiol; 2000 Apr; 278(4):H1211-7. PubMed ID: 10749716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Ca2+-activated K+ channels in the protective effect of ACE inhibition against ischemic myocardial injury.
    Node K; Kitakaze M; Kosaka H; Minamino T; Mori H; Hori M
    Hypertension; 1998 Jun; 31(6):1290-8. PubMed ID: 9622144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ramiprilat attenuates hypoxia/reoxygenation injury to cardiac myocytes via a bradykinin-dependent mechanism.
    Wall TM; Linseman DA; Hartman JC
    Eur J Pharmacol; 1996 Jun; 306(1-3):165-74. PubMed ID: 8813629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-arginine limits myocardial cell death secondary to hypoxia-reoxygenation by a cGMP-dependent mechanism.
    Agulló L; García-Dorado D; Inserte J; Paniagua A; Pyrhonen P; Llevadot J; Soler-Soler J
    Am J Physiol; 1999 May; 276(5):H1574-80. PubMed ID: 10330241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that epithelium-derived relaxing factor released by bradykinin in the guinea pig trachea is nitric oxide.
    Figini M; Ricciardolo FL; Javdan P; Nijkamp FP; Emanueli C; Pradelles P; Folkerts G; Geppetti P
    Am J Respir Crit Care Med; 1996 Mar; 153(3):918-23. PubMed ID: 8630573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AT1-receptor antagonism improves endothelial function in coronary artery disease by a bradykinin/B2-receptor-dependent mechanism.
    Hornig B; Kohler C; Schlink D; Tatge H; Drexler H
    Hypertension; 2003 May; 41(5):1092-5. PubMed ID: 12654707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for nitric oxide generation in the cardiomyocytes: its augmentation by hypoxia.
    Kitakaze M; Node K; Komamura K; Minamino T; Inoue M; Hori M; Kamada T
    J Mol Cell Cardiol; 1995 Oct; 27(10):2149-54. PubMed ID: 8576931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the converting enzyme inhibitor cilazaprilat on endothelium-dependent responses.
    Mombouli JV; Nephtali M; Vanhoutte PM
    Hypertension; 1991 Oct; 18(4 Suppl):II22-9. PubMed ID: 1916998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dual effects of nitric oxide synthase inhibitors on ischemia-reperfusion injury in rat hearts.
    Kobara M; Tatsumi T; Takeda M; Mano A; Yamanaka S; Shiraishi J; Keira N; Matoba S; Asayama J; Nakagawa M
    Basic Res Cardiol; 2003 Sep; 98(5):319-28. PubMed ID: 12955405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of angiotensin-converting enzyme increases the nitric oxide levels in canine ischemic myocardium.
    Kitakaze M; Node K; Minamino T; Asanuma H; Ueda Y; Kosaka H; Kuzuya T; Hori M
    J Mol Cell Cardiol; 1998 Nov; 30(11):2461-6. PubMed ID: 9925380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biphasic response to bradykinin in isolated porcine iliac arteries is mediated by bradykinin B1 and B2 receptors.
    Persson K; Andersson RG
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):306-13. PubMed ID: 9475274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of bradykinin and eNOS in the anti-ischaemic effect of trandolapril.
    Cargnoni A; Comini L; Bernocchi P; Bachetti T; Ceconi C; Curello S; Ferrari R
    Br J Pharmacol; 2001 May; 133(1):145-53. PubMed ID: 11325804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of angiotensin-converting enzyme protects endothelial cell against hypoxia/reoxygenation injury.
    Fujita N; Manabe H; Yoshida N; Matsumoto N; Ochiai J; Masui Y; Uemura M; Naito Y; Yoshikawa T
    Biofactors; 2000; 11(4):257-66. PubMed ID: 11270506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.